Core Scientific Stock Up 84% as Fund Cuts Stake by $8.6 Million

Kintayl Capital sold 495,390 shares of Core Scientific (estimated $8.64M based on quarterly average), cutting its holding to 74,664 shares valued at $1.09M and reducing the stake from 6.3% to 0.66% of reported AUM; the fund’s net position change was a $9.14M decrease. Core Scientific reported Q4 revenue of about $79.8M (down from $94.9M prior year), with improved gross profit and rising colocation revenue but adjusted EBITDA still negative and heavy infrastructure investment ongoing. Shares were quoted at $15.81 as of the most recent Friday (up ~84% over the past year), so the sale is notable for positioning but unlikely to be a market-moving event on its own.

Analysis

The portfolio rotation implied by a large, concentrated holder materially trimming exposure forces two second-order dynamics: immediate price sensitivity to flows and a widening bid/ask for the name versus peers. With one less deep-pocketed buyer, headline moves will be amplified by retail and quant liquidity; expect intraday volatility spikes on crypto headlines and option expiries for at least 3–6 months.

Core Scientific’s strategic pivot from self-mining to colocation strengthens revenue durability but front-loads capital deployment and execution risk. That raises a timing mismatch: earnings and cash-flow inflection points sit on a 12–24 month runway while market positioning can unwind in weeks, so implied volatility will likely remain elevated until contracted power capacity ramps.

The dominant external catalysts to monitor are BTC price direction, regional power-price trajectories, and new large-scale colocation contracts becoming revenue-recognized. Any sustained BTC weakness or power-cost shock can quickly reverse the transition narrative; conversely, multi-year power contracts or announced hyperscaler/AI hosting deals will compress perceived risk and re-attract institutional ownership.

Key Decisions for Investors

• Short CORZW via a defined-risk put spread (buy 6-month 30% OTM put / sell 6-month 15% OTM put) size to risk 0.5–1.0% of book. Rationale: captures mean-reversion and flow-driven downside while limiting gamma bleed; take profits on 40–60% of premium if CORZW drops 25% intraday or IV contracts by 30%.
• Pair trade: Long QRVO / Short CORZW, 6–12 month horizon, 1:1 notional. Rationale: QRVO exposure to secular RF demand offers stable earnings growth versus CORZW’s transition risk; target 20–30% relative outperformance, stop-loss if pair fails to widen by 10% within 3 months.
• Tactical contrarian long CORZW only with a protective collar: buy shares on a >15% pullback from current levels and hedge with a 9–12 month collar (buy 20% OTM put, finance by selling a 40% OTM call). Cap position size to 0.5% of AUM; payout is asymmetric if the company proves colocation economics while downside is capped.
• Event hedge: buy 3-month BTC puts sized to cover estimated daily mining revenue exposure if you hold CORZW exposure. Rationale: mining economics are the immediate swing factor for valuation; this is a low-cost insurance if BTC drops >25% within a quarter.